Circulation 2022
Lets talk about it. What makes the story of GLP-1s particularly interesting is that it started nearly 20 years ago with a twice-daily injection called Byetta, which offered modest A1C reduction and less than 10% weight loss
The modulatory effects of combined therapy with GLP-1RAs and other drugs on tumor risk As GLP-1RAs continue to see expanding clinical application, it is imperative that clinicians give careful consideration to the potential adverse effects linked to combination therapies
Studies were identified through search of trial registries and databases (Medline, Embase, PsycINFO, CINAHL, Cochrane, Web of Science) from inception through February 2025 for randomized controlled trials, nonrandomized comparative trials, and observational studies
The journey toward an optimal oral GLP-1 is exemplified by the contrasting fates of Pfizers danuglipron and Eli Lillys orfoglipron
Does allulose make you feel less hungry after using it